Korean Circ J.  2007 Aug;37(8):373-379. 10.4070/kcj.2007.37.8.373.

Predictive Factors after Percutaneous Coronary Intervention in Young Patients with Acute Myocardial Infarction

• Cho JY
• Jeong MH
• Choi OJ
• Lee S
• Jeong SY
• Kim IS
• Cho JS
• Hwang SH
• Hwang SH
• Yoon NS
• Moon JY
• Hong YJ
• Kim JH
• Kim W
• Ahn YK
• Cho JG
• Park JC
• Kang JC

• KMID: 2029065
• DOI: http://doi.org/10.4070/kcj.2007.37.8.373

Abstract

BACKGROUND AND OBJECTIVES: Acute myocardial infarction (AMI) at a young age less than 40 years is an uncommon condition and it is characterized by multiple cardiovascular risk factors. We analyzed the risk factors of restenosis in AMI patients who underwent percutaneous coronary intervention (PCI), and these patients were under the age of 40 years.
SUBJECTS AND METHODS
Between January 1997 and December 2006, 88 out of the 121 young AMI patients (mean age: 35.6+/-4.0 years, 115 males) who underwent follow-up coronary angiography after PCI were divided into two groups: the patients without restenosis (group I: n=62, mean age: 35.6+/-3.9 years, 60 males) and the patients with restenosis (group II: n=26, mean age: 36.3+/-3.8 years, 23 males). The clinical and coronary angiographic characteristics were compared between the two groups.
RESULTS
Smoking (79.3%) was the most common risk factor in all the patients. The baseline clinical characteristics and baseline laboratory findings were not different between the two groups. There was no significant difference in the sex ratio (p=0.124). The Thrombolysis In Myocardial Infarction (TIMI) flows were not different between the two groups. The level of homocysteine (hcy) was significantly decreased from 12.4+/-8.8 micronmol/L to 9.3+/-3.8 micronmol/L in group I (p=0.011), but this was not changed significantly in group II (p=0.062). According to multiple logistic regression analysis, a high triglyceride level (>200 mg/dL) was an independent predictor of restenosis (p=0.046).
CONCLUSION
A high level of serum triglyceride is a predictive factor of restenosis after PCI in young age patients with acute myocardial infarction.

Keyword

Myocardial infarction; Coronary restenosis; Prognosis

MeSH Terms

Coronary Angiography
Coronary Restenosis
Follow-Up Studies
Homocysteine
Humans
Logistic Models
Myocardial Infarction*
Percutaneous Coronary Intervention*
Prognosis
Risk Factors
Sex Ratio
Smoke
Smoking
Triglycerides
Homocysteine
Smoke

Reference

1. Kim W, Jeong MH, Cho JY, et al. The preventive effect on in-stent restenosis of overlapped drug-eluting stents for treating diffuse coronary artery disease. Korean Circ J. 2006. 36:17–23.

2. Jeong MH, Kim SH, Ahn YK, et al. Predictive factors for second restenosis after coronary intervention. Catheter Cardiovasc Interv. 2000. 50:34–39.

3. Kim YA, Jeong MH, Cho JH, et al. Predictive factors for the restenosis after long coronary stent implantation. Korean Circ J. 2001. 31:39–44.

4. Shiraishi J, Kohno Y, Yamaguchi S, et al. Acute myocardial infarction in young Japanese adults. Circ J. 2005. 69:1454–1458.

5. Fournier JA, Sanchez A, Quero J, Fernandez-Cortacero JA, Gonzalez-Barrero A. myocardial infarction men aged 40 years less: A prospective clinical angiographic study. Clin Cardial. 1996. 19:631–636.

6. Jeong PH, Lee JY, Yoo BS, et al. Acute myocardial infarction in the young adult. Korean Circ J. 1998. 28:8–14.

7. Lim SY, Jeong MH, Yang BR, et al. Long-term clinical outcome after primary percutaneous coronary intervention in patients with acte myocardial infarction older than 75 years. Korean Circ J. 2005. 35:613–619.

8. Lee SH, Jeong MH, Park OY, et al. Early outcome and restenosis rate after coronary artery stenting in the elderly. Korean Circ J. 2001. 31:31–38.

9. Ahn YK, Jeong MH, Bom HS, et al. Myocardial infarction with Myomoya disease and pituitary gigantism in a young female patient. Jpn Cir J. 1999. 63:644–648.

10. Kim W, Jeong MH, Yeom JH, et al. A case of acute myocardial infarction in an eighteen-year-old male patient without specific underlying diseases. Korean J Med. 2002. 63:572–576.

11. Park WS, Jeong MH, Hong YJ, et al. A case of acute myocardial infarction after blunt chest trauma in a young man. J Korean Med Sci. 2003. 18:889–893.

12. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996. 93:879–888.

13. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007. 49:2129–2138.

14. Kim KH, Jeong MH, Hong SN, et al. The clinical effect of drug-eluting stents for the treatment of coronary in-stent restenosis. Korean Circ J. 2005. 35:443–447.

15. Karim MA, Miller DD, Farrar MA, et al. Histomorphometric and biochemical correlates of arterial procollagen gene expression during vascular repair after experimental angioplasty. Circulation. 1995. 91:2049–2057.

16. Indolfi C, Exposito G, Di Loranzo E, et al. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation. 1995. 92:1230–1235.

17. Shiraishi J, Kohno Y, Yamaguchi S, et al. Medium-term prognosis of young Japanese adult having acute myocardial infarction. Circ J. 2006. 70:518–524.

18. Malmberg K, Bavenholm P, Hamsten A. Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. J Am Coll Cardiol. 1994. 24:592–599.

19. Mattioli AV, Bonetti L, Zennaro M, Bertoncelli P, Mattioli G. Acute myocardial infarction in young patients: nutrition status and biochemical factors. Int J Cardiol. 2005. 101:185–190.

20. Anand S, Xie CC, Mehta S, et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol. 2005. 46:1845–1851.

21. Skelding KA, Mehta LS, Pica MC, et al. Primary percutaneous intervention for acute myocardial infarction in octogenarians: a single-center experience. Clin Cardiol. 2002. 25:363–366.

22. Sakai K, Nakagawa Y, Kimura T, et al. Comparison of results of coronary angioplasty for acute myocardial infarction in patients ≥75 years of age versus patients <75 years of age. Am J Cardiol. 2002. 89:797–800.

23. Kloner RA. No-reflow revisited. J Am Coll Cardiol. 1989. 14:1814–1815.

24. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of no-reflow after percutaneous coronary intervention. Circulation. 1994. 89:2514–2518.

25. Ellis SG, Popma JJ, Buchbinder M, et al. Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty. Circulation. 1994. 89:882–892.

26. Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006. 355:1093–1104.

27. Tsai JC, Wang H, Perrella MA, et al. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest. 1996. 97:146–153.

28. Miner SE, Hegele RA, Sparkes J, et al. Homocysteine, lipoprotein (a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study. Am Heart J. 2000. 140:272–278.

29. Morita H, Kurihara H, Kuwaki T, et al. Homocysteine as a risk factor for restenosis after coronary angioplasty. Thromb Haemost. 2000. 84:27–31.

30. Park OY, Jeong MH, Yang BR, et al. The effects of serum homocysteine on the restenosis after percutaneous coronary intervention. Korean Circ J. 2001. 31:560–566.